Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer

Cisplatin resistance remains one of the major obstacles when treating epithelial ovarian cancer. Because oxaliplatin and nedaplatin are effective against cisplatin-resistant ovarian cancer in clinical trials and signal transducer and activator of transcription 3 (STAT3) is associated with cisplatin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sheng, W.J., Jiang, H., Wu, D.L., Zheng, J.H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Associação Brasileira de Divulgação Científica 2013
Schlagworte:
Biomedical Sciences
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854422/
https://ncbi.nlm.nih.gov/pubmed/23969971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20133003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge